Attend these exciting industry sessions slated for Denver

Don’t miss out on a variety of diverse Industry Non-CME (INC) Programs held March 19-22, during the 2020 AAD Annual Meeting in Denver. At the sponsoring company’s discretion, these sessions present new research findings, showcase specialty innovations, conduct demonstrations, and host lively discussions. These informational programs do not qualify for CME credit and are independent of the official AAD Annual Meeting as planned by the Scientific Assembly Committee

Below is the full schedule of the INC Programs taking place during the 2020 AAD Annual Meeting. Please note that all content and registration information is under the control of the sponsoring company and is subject to change.

Thursday, March 19, 2020

Title: Cosmetic Treatment of Hyperpigmentation

Description: In this Industry Non-CME program, expert scientists and dermatologists will discuss the biology of hyperpigmentation, which is a global skincare concern and one of the most challenging skin conditions to address.

Host: Clinique Laboratories

Location: Embassy Suites Denver, Crestone Ballroom

Registration time: 6:30 p.m.

Program time: 7 to 9 p.m.

Pre-register at:

Title: Beyond Skin Deep

Description: Join The Atlantic for an evening of conversations with patients and medical experts discussing how skin conditions can affect physical and mental health. Underwritten by Pfizer 

Host: Pfizer Inc.

Location: Embassy Suites Denver, Cripple Creek Ballroom

Registration time: 6:30 p.m.

Program time: 7 to 9 p.m.

Pre-register at:


Friday, March 20, 2020

Title: A Virtual Reality View: Pediatric & Adolescent Patients with Moderate-to-Severe Atopic Dermatitis

Description: While guidelines regarding the management of AD in children have been published, variability persists in practice. Treatment inconsistencies and the chronic and relapsing nature of AD can lead to frustration for patients, family, and caregivers when managing AD. This program will focus on providing AD caregivers an update on recent pathophysiological findings that drive new therapeutic targets; reviewing severity and diagnosis of AD; and discussing the clinical profiles of existing and emerging agents, with focus on treatment individualization.

Host: Med Learning Group. This activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.

Location: Sheraton Denver, Majestic Ballroom

Registration time: 6:30 p.m.

Program Time: 7 to 8 p.m.

To preregister for the live event, please visit or call 207-406-4248.

Title: New Frontiers in Psoriasis: Evolving Treatment Goals, Patient Expectations, and Therapeutic Targets

Description: An educational symposium discussing evolving expectations in the treatment of psoriasis and how to measure the success of treatment for the patient as well as expert insights into how the IL-17 family of cytokines may be essential to addressing the complexities of the disease.

Host: UCB, Inc.

Location: Embassy Suites, Cripple Creek Ballroom

Registration time: 6:30 p.m.

Program time: 7 to 8:30 p.m.

Pre-registration is provided for this INC program at: UCB, Inc. is at Booths 3950 and 3955 in the exhibit hall.

Title: Live Medical Crossfire: How Do Recent Pathophysiological Findings in Pustular Psoriasis Have the Potential to Shape a New Treatment Paradigm?

Description: Pustular psoriasis outbreaks can be severe and life-threatening but early diagnosis is hindered by its rarity, heterogeneous presentation, and lack of consistent classification. Furthermore, at present there are no standard therapies and only limited evidence-based guidance with available agents. However, recent clinical, histological, and genetic evidence has provided new insights into the pathophysiology of pustular psoriasis, allowing for new therapeutic targets with novel treatments. During this live Medical Crossfire®, a multidisciplinary panel of experts will share their insights on diagnosis and disease severity assessment, possible pathophysiological pathways involved in the development of the disease, and the clinical profiles and mechanisms of action of available and emerging agents for the treatment of adults with pustular psoriasis. Throughout the program, there will be a focus on individualizing disease management to improve patient outcomes and quality of life. Participants will be encouraged to interact with the panel through audience response technology.

Host: Physicians’ Education Resource, LLC (PER) and supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals Inc.

Location: Sheraton Denver, Vail room

Registration time: 6:30 p.m.

Program time: 7:00 p.m. to 8:30 p.m.

Register at:


Saturday, March 21, 2020

Title: A Timely Intervention: Early Clues to Identify the Patient with PsO at Risk of PsA

Description: This program is designed to educate dermatology practitioners to diagnose PsA early in their patients with psoriasis, to recognize the preclinical indicators of PsA risk, and to help guide clinical decisions based on the PsA risk profiles of their patients in order to treat psoriatic disease with therapies that cover the spectrum of psoriatic manifestations.

Host: Novartis

Location: Sheraton Denver, Grand Ballroom 1

Registration time: 6:30 p.m.

Program time: 7 to 8 p.m.

Register at:

Title: Looking Beyond the Skin: How to Better Assess Atopic Dermatitis to Improve Care for Your Patients

Description: This program will provide clinicians with an overview of scales used to assess signs and symptoms of atopic dermatitis, followed by an in-depth discussion of scales that can be used to assess the multidimensional burden of the disease. Tools used to assess patient’s overall health in atopic dermatitis, and how to use them in clinical practice, will be described. In addition, a tool developed to assess disease control in atopic dermatitis will be introduced and discussed within the context of similar tools developed for other disease states.

Host: Regeneron & Sanofi Genzyme

Location: Sheraton Denver, Grand Ballroom 2

Registration time: 7:30 p.m.

Program time: 8 to 9 p.m.

Registration will begin at 7:30 pm


Sunday, March 22, 2020

Title: Diving Deeper into the Role of Systemic Therapy in Advanced CSCC

Description: For many patients with advanced cutaneous squamous cell carcinoma (CSCC), surgery just isn’t enough. Let’s take a deeper dive into the clinical data to explore when systemic therapy should be considered. Join us for an interactive session to examine the emerging possibilities in personalized management of advanced CSCC.

In this activity, experts in skin cancer will use real-world clinical examples to illustrate when a systemic approach may be considered to optimize patient management and outcomes. Come engage with the faculty as they make the case for a deeper approach to advanced CSCC management.

Host: Answers in CME

Location: Hyatt Regency Denver, Centennial E room

Registration time: 6:30 p.m.

Program time: 7 to 8 p.m.

Title: Let’s Talk About an Option for Your Patients with Challenging Manifestations of Psoriasis

Description: An engaging presentation on a treatment option for patients with moderate to severe plaque psoriasis with involvement of difficult to treat areas, who are candidates for phototherapy or systemic therapy.

Host: Amgen Inc.

Location: Hyatt Regency, Centennial D room

Registration time: 6:30 p.m.

Program time: 7 to 8:30 p.m.

Title: Innovation in Psoriasis Research: Steps Toward A Patient-Centered Approach

Description: This Bristol-Myers Squibb–sponsored dialectic symposium, led by dermatology experts, will focus on innovative approaches to psoriasis research. The conversation will include an exploration of the cytokine signaling pathways involved in psoriasis pathogenesis, drug development processes based on genetic and immunologic rationale, and how clinical trials may inform clinical practice. Please join us for this engaging scientific discussion.

Host: Bristol-Myers Squibb

Location: Embassy Suites Denver, Silverton Ballroom

Registration time: 6:30 p.m.

Program time: 7 to 9 p.m.